Anthropic启动药物发现项目,瞄准制药公司不盈利的疾病

Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable

精选理由

Anthropic自己下场搞药了,专挑大厂不赚钱的病,还说AI能把研发周期砍到七八年。

AI 摘要

Anthropic宣布启动自有药物发现项目,专注于制药行业认为无利可图的疾病领域。诺华CEO Vas Narasimhan预计AI能将药物开发周期从12年缩短至7-8年,并将成功率从8%提升至16%。该项目旨在利用Anthropic的AI能力加速被忽视疾病的疗法研发。

原文 · Decoder

Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable

Anthropic is launching its own drug development program for neglected diseases that the pharmaceutical industry considers unprofitable. Novartis CEO Vas Narasimhan thinks AI could cut development time from twelve years to seven or eight and double the success rate from 8 to 16 percent. The article Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable appeared first on The Decoder .

Anthropic启动药物发现项目,瞄准制药公司不盈利的疾病 · AI 热点